Dr. Hsu is co-founder of Xilis. He is a medical oncologist and is currently Associate Professor of Medicine at Duke University Medical Center. Dr. Hsu’s clinical interests include gastrointestinal malignancies and colorectal cancer. His lab focuses on using patient models of cancer, high-throughput genomic and proteomic technologies to develop new therapies and diagnostics for cancer. He received his MD and PhD from the University of North Carolina at Chapel Hill and completed his medical training at UT Southwestern Medical Center and Duke Medical Center.
